Aisling Carr

1.0k total citations
30 papers, 188 citations indexed

About

Aisling Carr is a scholar working on Neurology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Aisling Carr has authored 30 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Genetics. Recurrent topics in Aisling Carr's work include Peripheral Neuropathies and Disorders (13 papers), Hereditary Neurological Disorders (8 papers) and Glioma Diagnosis and Treatment (5 papers). Aisling Carr is often cited by papers focused on Peripheral Neuropathies and Disorders (13 papers), Hereditary Neurological Disorders (8 papers) and Glioma Diagnosis and Treatment (5 papers). Aisling Carr collaborates with scholars based in United Kingdom, United States and Australia. Aisling Carr's co-authors include Mary M. Reilly, Michael P. Lunn, Alexander M. Rossor, Lavinia Spain, Samra Turajlic, Zayd Tippu, James Larkin, Ana L. Pelayo‐Negro, H S Chandrashekar and Steven S. Scherer and has published in prestigious journals such as Blood, Journal of Neurology Neurosurgery & Psychiatry and Journal of the Neurological Sciences.

In The Last Decade

Aisling Carr

25 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aisling Carr United Kingdom 7 89 85 45 40 36 30 188
Daisuke Muta Japan 10 221 2.5× 51 0.6× 38 0.8× 31 0.8× 33 0.9× 18 321
Huanyu Meng China 10 125 1.4× 22 0.3× 38 0.8× 38 0.9× 88 2.4× 28 280
Jürgen Grauvogel Germany 8 67 0.8× 24 0.3× 15 0.3× 47 1.2× 31 0.9× 16 181
Zhibiao Chen China 11 105 1.2× 38 0.4× 24 0.5× 23 0.6× 144 4.0× 21 306
Yoshimi Kinoshita Japan 7 103 1.2× 24 0.3× 28 0.6× 66 1.6× 117 3.3× 12 205
Harold H G Tan Netherlands 8 216 2.4× 30 0.4× 80 1.8× 126 3.1× 88 2.4× 11 346
Clarice Patrono Italy 9 27 0.3× 77 0.9× 20 0.4× 37 0.9× 126 3.5× 20 238
Aya Haggiagi United States 8 94 1.1× 19 0.2× 93 2.1× 87 2.2× 34 0.9× 20 244
María Paula Marks Argentina 5 55 0.6× 33 0.4× 28 0.6× 19 0.5× 57 1.6× 6 151
Jason Correia New Zealand 7 58 0.7× 50 0.6× 12 0.3× 26 0.7× 26 0.7× 21 191

Countries citing papers authored by Aisling Carr

Since Specialization
Citations

This map shows the geographic impact of Aisling Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisling Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisling Carr more than expected).

Fields of papers citing papers by Aisling Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisling Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisling Carr. The network helps show where Aisling Carr may publish in the future.

Co-authorship network of co-authors of Aisling Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Aisling Carr. A scholar is included among the top collaborators of Aisling Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisling Carr. Aisling Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Coakley, Gerald, Maria Leandro, Corinne Fisher, et al.. (2025). Haemophagocytic lymphohistiocytosis precipitated by lamotrigine. Practical Neurology. 26(2). 146–149.
3.
Vonberg, Frederick W., Imran Malik, Maeve O’Reilly, et al.. (2025). Neurotoxic complications of chimeric antigen receptor (CAR) T-cell therapy. Journal of Neurology Neurosurgery & Psychiatry. 96(7). 665–678. 1 indexed citations
5.
Marandino, Laura, et al.. (2025). Neurological immune-related adverse events with checkpoint inhibitor therapy: challenges for the neurologist. Journal of Neurology Neurosurgery & Psychiatry. 96(11). 1024–1037.
6.
Carr, Aisling, Frederick W. Vonberg, Kate Young, et al.. (2024). Neurological complications of immune checkpoint inhibitors: a practical guide. Practical Neurology. 25(2). 116–126. 7 indexed citations
7.
Stancanelli, Claudia, Ekawat Vichayanrat, Laura Sander, et al.. (2024). Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker. Clinical Autonomic Research. 34(3). 341–352. 4 indexed citations
8.
Kapoor, Mahima, Anthony Khoo, Michael P. Lunn, Stephen Reddel, & Aisling Carr. (2024). Immunoglobulin use in neurology: a practical approach. Practical Neurology. 25(3). 228–240. 3 indexed citations
9.
Carr, Aisling, et al.. (2023). Toxic neuropathies: a practical approach. Practical Neurology. 23(2). 120–130. 5 indexed citations
10.
Foster, Michael A., Michael P. Lunn, & Aisling Carr. (2023). First-line immunosuppression in neuromuscular diseases. Practical Neurology. 23(4). 327–338. 7 indexed citations
11.
Matthews, Emma, Robert D. S. Pitceathly, Michael G. Hanna, et al.. (2021). Long-term Safety and Efficacy of Mexiletine in Myotonic Dystrophy Types 1 and 2. Neurology Clinical Practice. 11(5). e682–e685. 5 indexed citations
12.
Kapoor, Mahima, Ryan Keh, Sarah A. Morrow, et al.. (2021). Subcutaneous immunoglobulin dose titration to clinical response in inflammatory neuropathy. Journal of Neurology. 268(4). 1485–1490. 5 indexed citations
13.
Keddie, Stephen, Zane Jaunmuktane, Sebastian Brandner, et al.. (2020). Peripheral nerve neurolymphomatosis: Clinical features, treatment, and outcomes. Muscle & Nerve. 62(5). 617–625. 16 indexed citations
14.
Lindsay, Jindriska, Stephen Keddie, Aisling Carr, et al.. (2020). Neuropathy with IgM Gammopathy: Incidence, Characteristics and Management, a Rory Morrison W.M.U.K Registry Analysis. Blood. 136(Supplement 1). 1–2. 3 indexed citations
15.
Keh, Ryan, Mahima Kapoor, David Gosal, et al.. (2019). Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?. Journal of the Neurological Sciences. 408. 116527–116527. 5 indexed citations
16.
Brown, Rachel, Lewis Au, Lavinia Spain, et al.. (2019). 208 Immune checkpoint inhibitor-related neurotoxicity: a case series. Journal of Neurology Neurosurgery & Psychiatry. 90(12). e52.3–e52. 1 indexed citations
17.
Spain, Lavinia, Zayd Tippu, James Larkin, Aisling Carr, & Samra Turajlic. (2019). How we treat neurological toxicity from immune checkpoint inhibitors. ESMO Open. 4(Suppl 4). e000540–e000540. 35 indexed citations
18.
Keddie, Stephen, et al.. (2018). POEMS neuropathy: optimising diagnosis and management. Practical Neurology. 18(4). 278–290. 13 indexed citations
19.
Keddie, Stephen, Zane Jaunmuktane, Sebastian Brandner, et al.. (2018). A diagnostic conundrum. Practical Neurology. 18(2). 137–142.
20.
Rossor, Alexander M., Aisling Carr, Helen Devine, et al.. (2017). Peripheral neuropathy in complex inherited diseases: an approach to diagnosis. Journal of Neurology Neurosurgery & Psychiatry. 88(10). 846–863. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026